Company Quick10K Filing
Bio-Rad Laboratories
10-Q 2020-06-30 Filed 2020-07-31
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-03-02
10-Q 2019-09-30 Filed 2019-11-01
10-Q 2019-06-30 Filed 2019-08-06
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-05
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-04-16
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-02
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-06
10-K 2014-12-31 Filed 2015-03-02
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-06
10-K 2013-12-31 Filed 2014-03-18
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-18
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-02-29
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-08-04
10-Q 2011-03-31 Filed 2011-05-06
10-K 2010-12-31 Filed 2011-02-28
10-Q 2010-09-30 Filed 2010-11-09
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-02-26
8-K 2020-07-30 Earnings, Other Events, Exhibits
8-K 2020-05-21
8-K 2020-05-06
8-K 2020-04-28
8-K 2020-04-01
8-K 2020-02-25
8-K 2020-02-13
8-K 2019-12-05
8-K 2019-11-21
8-K 2019-10-31
8-K 2019-08-20
8-K 2019-08-01
8-K 2019-05-08
8-K 2019-05-02
8-K 2019-04-22
8-K 2019-04-15
8-K 2019-04-02
8-K 2019-03-19
8-K 2019-03-18
8-K 2019-02-28
8-K 2019-01-02
8-K 2018-12-04
8-K 2018-11-01
8-K 2018-08-07
8-K 2018-06-14
8-K 2018-05-08
8-K 2018-04-18
8-K 2018-03-19
8-K 2018-03-16
8-K 2018-02-27
8-K 2018-02-13

Bio-Rad Laboratories Financials

BIO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Illumina (ILMN) 44,722 69% 35.1 14% 7,089 2,650 3,458 2,395 973 1,255 44,038
Agilent Technologies (A) 24,292 54% 18.0 9% 9,452 4,704 5,163 2,805 877 1,368 24,690
Mettler Toledo (MTD) 17,554 58% 26.5 21% 2,636 2,198 2,983 1,720 550 700 18,558
Waters (WAT) 15,473 18% 31.8 15% 2,561 2,446 2,405 428 392 513 16,324
Bio-Rad Laboratories (BIO) 10,341 55% 12.0 5% 7,177 2,046 2,304 1,259 377 850 10,215
PerkinElmer (PKI) 9,500 48% 25.3 4% 6,489 3,782 2,835 1,374 234 449 11,362
Bruker (BRKR) 6,836 48% 23.2 9% 2,352 1,507 2,026 972 207 305 7,055
Coherent (COHR) 3,296 34% 37.6 3% 2,083 798 1,431 486 54 79 2,977
Accelerate Diagnostics (AXDX) 1,034 45% -15.4 -58% 147 137 8 3 -85 -72 1,112
Pacific Biosciences of California (PACB) 862 33% -7.4 -79% 146 95 82 27 -115 -113 840
Fluidigm (FLDM) 852 40% -16.2 -19% 269 107 117 46 -52 -51 824
Quanterix (QTRX) 607 39% -12.8 -22% 176 39 52 20 -39 -39 501
EyePoint Pharmaceuticals (EYPT) 194 67% -2.9 -101% 79 63 12 8 -80 -72 209
Harvard Bioscience (HBIO) 130 55% 33.8 -1% 163 86 119 66 -2 5 175
HTG Molecular Diagnostics (HTGM) 36 48% 0.2 -29% 51 23 14 7 -15 -13 -2
Precipio (PRPO) 20 4% -2.2 -42% 23 7 6 0 -9 -9 19
Astrotech (ASTC) 11 17% -1.4 -144% 5 4 0 0 -7 -7 10
Bionano Genomics (BNGO) 7 29% 0.1 -81% 19 27 11 3 -16 -13 -1
Aethlon Medical (AEMD) 0 0% 0.1 -579% 1 1 0 0 -7 -7 -0

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash614631907628670671574534456426463369367292332365385425413426450507458404419418456292322329384408404436434459583563
Accounts Receivable335369388389395375399388374376399378396383423384379354378342354342391381366368372373393420465430404382392392378356
Inventory370403398430449446434463449458448467485524501514521516471478501513490533542556525560581602595612591601584590590588
PP&E3063228128428758628829259389741,0121,0281,0321,0661,0871,1061,1301,0881,0891,0771,1091,1061,1171,1591,1791,2171,2271,2621,2781,2971,3051,3211,2891,2961,3271,3311,3491,347
Assets2,5272,6823,0632,9093,0442,9703,0973,1883,1693,3033,4373,4573,4833,2803,3893,4413,4683,3863,3413,3263,5253,6663,7123,7533,8754,0203,8513,9534,1434,1864,2736,2156,3866,7195,6116,8637,6477,177
Accounts Payable121113129110119113131119129132149131125127129122133135122
Long-Term Debt734734731732732732732732732733733733436436436436436436436436436436434434434434434434434435435439439439438438438
Liabilities1,2241,2541,5221,2951,3181,2761,3521,3481,3161,3681,4251,4261,4121,1561,2021,2091,2181,2091,1561,1281,1661,2371,2211,2091,2601,3171,2641,2451,3321,3371,3431,7271,7471,8181,5911,9992,1602,046
Stockholders' Equity1,2851,4241,5371,6121,7261,6931,7441,8401,8521,9352,0112,0312,0712,1242,1872,2332,2502,1772,1852,1992,3592,4302,4912,5442,6152,7032,5872,7072,8112,8482,9304,4884,6394,9004,0204,8645,4875,131
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue468472534485522517550486510499574500525505603509537531598473506470571471517509572500505535621552576545617554573561
Cost of Revenue199205234208229220239208223225260228225221280234240242281203227207262207237229257230231230276249274258284242265254
Gross Profit268266300278293296311279288274314271300284323275297289317270280263308264280279314270273305345302302287333312308307
R&D44434543484550535249605253535653565359474743564952505549636176494749485048
SG&A156149177168177177175171162160189186195202215202196203208189193187193190206201220195213197202209210201208201202
Tax-1713-1115371914252326141428181181711791185894-89-421122077281262171-76
Net Income39456833404659314942422035-730732123918281750121818-211252783657268269-828865599-259
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating6710020110517935747199201963736981834029398236-7775295-5662286940786243155100
Cash Investing-61-52-77-81-56-170-86-151-104-72-115-28180-42-39-63-39-49-28-28-27-84-51-59-53-50-110-37-15-13-19-84-30-23-15-110
Cash Financing3222-21512-2433434-32243324-032403331-1-343-2-22-16-4